Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628846 · ClinicalTrials.gov registry record
Opioid Use After Traumatic Injury in Adolescents
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 123
- Enrollment target
NCT03628846: Completed study, sponsored by Indiana University.
NCT03628846 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 123 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03628846 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
Study Summary
Currently, 1 in 8 adolescents continue to receive prescription opioids a year or more after injury. By longitudinally surveying patients, we can identify risk factors and pathways to nonmedical opioid use. Furthermore, by assessing whether pain management and mental health treatment after injury moderates sustained opioid use and prescription opioid misuse, we can create targeted interventions to reduce future nonmedical opioid use in adolescents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2023-04-30 |
What the finished NCT03628846 record still lists
NCT03628846 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03628846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03628846 about?
NCT03628846 is a clinical study titled "Opioid Use After Traumatic Injury in Adolescents". Currently, 1 in 8 adolescents continue to receive prescription opioids a year or more after injury. By longitudinally surveying patients, we can identify risk factors and pathways to nonmedical opioid use. Furthermore, by assessing whether pain management and mental health treatment after injury mod...
What is the current status of trial NCT03628846?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2018-07-01. Estimated completion is 2023-04-30.
Who is sponsoring clinical trial NCT03628846?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI